Vivesto AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-14 EDT			5-day change	1st Jan Change
8.720 ^SEK	+3.32%		-3.96%	-35.41%

07-07	Vivesto chairman Peter Zonabend increases his shareholding	FW
07-01	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW

Published on 11/24/2025 at 11:35 am EST - Modified on 11/24/2025 at 05:40 pm EST

S&P Capital IQ

Presenter Speech
Mikael Magnusson (Attendees)

The clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update. Today, we will hear about the company with a focus towards the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

07-07	Vivesto chairman Peter Zonabend increases his shareholding	FW
07-01	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW
07-01	Vivesto Completes Recruitment in Paccal Vet Dose-Finding Study in Cats and Determines Maximum Tolerated Dose	CI
06-26	Vivesto Completes Enrollment in Canine Study	FW
06-26	Vivesto Completes Recruitment in Paccal Vet Dog Pilot Study	CI
06-16	Vivesto AB Reports Positive Results From Intravenous Cantrixil Pharmacokinetic And Toxicology Study	CI
06-16	Vivesto reports positive results for intravenous Cantrixil	FW
06-05	Sweden's Vivesto Names New Finance Chief	MT
06-05	Vivesto appoints Björn Svanström as new CFO	FW
06-04	Vivesto AB Announces Chief Financial Officer Changes	CI
05-26	DNB Carnegie adjusts Vivesto fair value following reverse stock split	FW
05-20	Vivesto trades on Nasdaq Stockholm today following 1:100 reverse stock split	FW
05-20	Calendar Wednesday May 20	FW
05-13	Vivesto sets record date for reverse share split as May 21, 2026	RE
05-13	Vivesto sets timetable for reverse stock split	FW